Le Lézard16h
ELAHERE® (mirvetuximab soravtansine-gynx) Shows Consistent Survival Benefit in Long-Term Analysis for Certain Ovarian Cancer Patients
AbbVie today announced the final analysis of the confirmatory Phase 3 MIRASOL trial evaluating the efficacy and safety of ELAHERE® (mirvetuximab soravtansine-gynx) in women with folate receptor alpha ...
Designer Ray-Ban Metas, An EV to Mock Tesla, and Portable Pizzas—Here’s Your Gear News of the Week
Plus: iRobot unveils its new robo vacs, JBL pimps its most beloved speakers, a bright future for TCL TVs, and more.